J. Craig Rowlands

4.2k total citations
59 papers, 2.1k citations indexed

About

J. Craig Rowlands is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, J. Craig Rowlands has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Health, Toxicology and Mutagenesis, 30 papers in Cancer Research and 8 papers in Pathology and Forensic Medicine. Recurrent topics in J. Craig Rowlands's work include Carcinogens and Genotoxicity Assessment (30 papers), Toxic Organic Pollutants Impact (29 papers) and Effects and risks of endocrine disrupting chemicals (27 papers). J. Craig Rowlands is often cited by papers focused on Carcinogens and Genotoxicity Assessment (30 papers), Toxic Organic Pollutants Impact (29 papers) and Effects and risks of endocrine disrupting chemicals (27 papers). J. Craig Rowlands collaborates with scholars based in United States, India and United Kingdom. J. Craig Rowlands's co-authors include Jan-Åke Gustafsson, Robert A. Budinsky, Thomas M. Badger, Ted W. Simon, Martin J. J. Ronis, Reza Hakkak, Richard A. Becker, Grace Patlewicz, M. Sue Marty and Jan-Ακε Gustafsson and has published in prestigious journals such as PLoS ONE, Hepatology and Chemosphere.

In The Last Decade

J. Craig Rowlands

58 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Craig Rowlands United States	27	985	579	542	215	205	59	2.1k
Mirjam Luijten Netherlands	29	889 0.9×	815 1.4×	1.1k 2.0×	168 0.8×	114 0.6×	102	2.8k
Penelope A. Fenner-Crisp United States	19	1.5k 1.5×	794 1.4×	668 1.2×	301 1.4×	72 0.4×	36	2.9k
J. Odum United Kingdom	25	1.3k 1.3×	574 1.0×	548 1.0×	514 2.4×	205 1.0×	52	2.7k
John P. Groten Netherlands	33	1.3k 1.3×	419 0.7×	688 1.3×	113 0.5×	78 0.4×	87	3.1k
H. Tinwell United Kingdom	31	1.3k 1.3×	1.1k 1.8×	925 1.7×	509 2.4×	163 0.8×	114	2.9k
Mark R. Fielden United States	24	504 0.5×	332 0.6×	659 1.2×	178 0.8×	107 0.5×	42	1.7k
Edward W. Carney United States	30	658 0.7×	343 0.6×	790 1.5×	327 1.5×	44 0.2×	88	2.6k
Lois D. Lehman‐McKeeman United States	32	698 0.7×	532 0.9×	954 1.8×	86 0.4×	125 0.6×	93	2.9k
Majorie B.M. van Duursen Netherlands	25	773 0.8×	269 0.5×	408 0.8×	236 1.1×	146 0.7×	83	1.9k
Vicki L. Dellarco United States	28	1.3k 1.3×	1.2k 2.1×	753 1.4×	173 0.8×	90 0.4×	61	3.2k

Countries citing papers authored by J. Craig Rowlands

Since Specialization

Citations

This map shows the geographic impact of J. Craig Rowlands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Craig Rowlands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Craig Rowlands more than expected).

Fields of papers citing papers by J. Craig Rowlands

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Craig Rowlands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Craig Rowlands. The network helps show where J. Craig Rowlands may publish in the future.

Co-authorship network of co-authors of J. Craig Rowlands

This figure shows the co-authorship network connecting the top 25 collaborators of J. Craig Rowlands. A scholar is included among the top collaborators of J. Craig Rowlands based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Craig Rowlands. J. Craig Rowlands is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Phadnis-Moghe, Ashwini S., Wei‐Min Chen, Jinpeng Li, et al.. (2016). Immunological characterization of the aryl hydrocarbon receptor (AHR) knockout rat in the presence and absence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicology. 368-369. 172–182. 14 indexed citations

Kleinstreuer, Nicole, Kristie Sullivan, David Allen, et al.. (2016). Adverse outcome pathways: From research to regulation scientific workshop report. Regulatory Toxicology and Pharmacology. 76. 39–50. 46 indexed citations

Harrill, Joshua, Abraham Nyska, Renee Hukkanen, et al.. (2015). Aryl hydrocarbon receptor knockout rats are insensitive to the pathological effects of repeated oral exposure to 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin. Journal of Applied Toxicology. 36(6). 802–814. 26 indexed citations

Becker, Richard A., Katie Paul Friedman, Ted W. Simon, et al.. (2015). An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity—Proof of concept. Regulatory Toxicology and Pharmacology. 71(3). 398–408. 42 indexed citations

Embry, Michelle R., Ammie N. Bachman, David R. Bell, et al.. (2014). Risk assessment in the 21st century: Roadmap and matrix. Critical Reviews in Toxicology. 44(sup3). 6–16. 94 indexed citations

Harrill, Joshua, Renee Hukkanen, Brian C. Gilger, et al.. (2013). Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice. Toxicology and Applied Pharmacology. 272(2). 503–518. 68 indexed citations

Budinsky, Robert A., Dieter Schrenk, Ted W. Simon, et al.. (2013). Mode of action and dose–response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study. Critical Reviews in Toxicology. 44(1). 83–119. 61 indexed citations

Rowlands, J. Craig, Robert A. Budinsky, B. Bhaskar Gollapudi, et al.. (2013). A Genomics-Based Analysis of Relative Potencies of Dioxin-Like Compounds in Primary Rat Hepatocytes. Toxicological Sciences. 136(2). 595–604. 6 indexed citations

Rowlands, J. Craig, Jonathan D. Urban, Daniele Wikoff, & Robert A. Budinsky. (2011). An Evaluation of Single Nucleotide Polymorphisms in the Human Aryl Hydrocarbon Receptor-Interacting Protein (AIP) Gene. Drug Metabolism and Pharmacokinetics. 26(4). 431–439. 13 indexed citations

10.

Urban, Jonathan D., Robert A. Budinsky, & J. Craig Rowlands. (2011). Single Nucleotide Polymorphisms in the Human Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) Gene. Drug Metabolism and Pharmacokinetics. 26(6). 637–645. 6 indexed citations

11.

Kopec, Anna K., Lyle D. Burgoon, Ashley R. Burg, et al.. (2010). Automated Dose-Response Analysis and Comparative Toxicogenomic Evaluation of the Hepatic Effects Elicited by TCDD, TCDF, and PCB126 in C57BL/6 Mice. Toxicological Sciences. 118(1). 286–297. 51 indexed citations

12.

Bazzi, Rana, Tracey D. Bradshaw, J. Craig Rowlands, Malcolm F. G. Stevens, & David Bell. (2009). 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole is a ligand and shows species-specific partial agonism of the aryl hydrocarbon receptor. Toxicology and Applied Pharmacology. 237(1). 102–110. 26 indexed citations

13.

Rowlands, J. Craig, et al.. (2006). FDA perspectives on health claims for food labels. Toxicology. 221(1). 35–43. 30 indexed citations

14.

Rowlands, J. Craig. (2002). Determining the Safety of Bioengineered Microorganisms Bioengineered microorganisms have a history of safe use in the food industry thanks to a well-developed risk-assessment process. Food technology. 56(10). 28–31. 2 indexed citations

15.

Rowlands, J. Craig. (2002). Altered Mammary Gland Differentiation and Progesterone Receptor Expression in Rats Fed Soy and Whey Proteins. Toxicological Sciences. 70(1). 40–45. 21 indexed citations

16.

Rowlands, J. Craig, Mark A. Berhow, & Thomas M. Badger. (2002). Estrogenic and antiproliferative properties of soy sapogenols in human breast cancer cells in vitro. Food and Chemical Toxicology. 40(12). 1767–1774. 50 indexed citations

17.

Rowlands, J. Craig, Ling He, Reza Hakkak, Martin J. J. Ronis, & Thomas M. Badger. (2001). Soy and Whey Proteins Downregulate DMBA-Induced Liver and Mammary Gland CYP1 Expression in Female Rats. Journal of Nutrition. 131(12). 3281–3287. 58 indexed citations

18.

Rowlands, J. Craig, et al.. (2000). Chronic Intragastric Infusion of Ethanol-Containing Diets Induces CYP3A9 While Decreasing CYP3A2 in Male Rats. Journal of Pharmacology and Experimental Therapeutics. 295(2). 747–752. 14 indexed citations

19.

Rowlands, J. Craig & Jan-Åke Gustafsson. (1997). Aryl Hydrocarbon Receptor-Mediated Signal Transduction. Critical Reviews in Toxicology. 27(2). 109–134. 434 indexed citations

20.

Rowlands, J. Craig, Iain J. McEwan, & Jan-Ακε Gustafsson. (1996). Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors.. Molecular Pharmacology. 50(3). 538–548. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact